Policy & Regulation
Ferring's Propess Approved in Japan for Treatment for Cervical Ripening
24 January 2020 - - Swiss pharmaceutical company Ferring Pharmaceuticals' Propess (dinoprostone) has been approved by the Minister of Health, Labour and Welfare in Japan for initiation of ce...
Poxel Names Moller as Chief Scientific Officer
24 January 2020 - - French biopharmaceutical company POXEL SA has appointed David E. Moller, MD, as chief scientific officer, the company said.

Moller will be responsible for leading...
The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of Tapezza for Thyroid Eye Disease
24 January 2020 - - The New England Journal of Medicine has published comprehensive results of the Phase 3 OPTIC clinical trial evaluating Tapezza (teprotumumab-trbw) for Thyroid E...
PledPharma reports issue by FDA of clinical hold in US on phase III POLAR programme
24 January 2020 - PledPharma AB (STO: PLED), an integrated pharmaceutical drug development company, announced on Thursday that the US Food and Drug Administration (FDA) has issued a clinical hold in t...
Gateway Health names new chief human resources officer
24 January 2020 - Gateway Health, a managed care organisation, has named Rhonda Curry as its new chief human resources officer, it was reported on Thursday.In the new role, Curry will manage all assoc...
Twist Bioscience Forges Drug Discovery Collaboration with Schrödinger
23 January 2020 - - US-based synthetic biology company Twist Bioscience Corp. (NASDAQ: TWST) has forged a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeut...